Meeting
2013 ASCO Annual Meeting
Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine, vincristine, and cytarabine for primary CNS lymphoma (PCNSL) in the elderly: An Anocef and Goelams Intergroup study.
Authors
Antonio Marcilio Padula Omuro
APHP-CHU Pitié-Salpêtrière, Paris, France
Antonio Marcilio Padula Omuro , Oliver L. Chinot , Luc Taillandier , Herve Ghesquieres , Carole Soussain , Vincent Delwail , Thierry Lamy , Remy Gressin , Sylvain Choquet , Pierre-Louis Soubeyran , Jean Philippe Maire , Alexandra Benouaich Amiel , Sophie Lebouvier-Sadot , Emmanuel Gyan , Maryline Barrie , Monica Sierra del Rio , Alberto Gonzalez , Caroline Houillier , Marie-Laure Tanguy , Khê Hoang-Xuan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Clinical Trial Registration Number
NCT00503594
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2032)
DOI
10.1200/jco.2013.31.15_suppl.2032
Abstract #
2032
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.
First Author: Jon Glass
Poster
2023 ASCO Annual Meeting
Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R-MPV for patients with a newly diagnosed primary central nervous system lymphoma (PCNSL).
First Author: Marion Alcantara
Poster
2020 ASCO Virtual Scientific Program
Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
First Author: Donna Molaie
Poster
2020 ASCO Virtual Scientific Program
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of induction therapy in Alliance 51101.
First Author: Tracy Batchelor